PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jan-2022 Oxurion Provides Update on Clinical Pipeline Progress Oxurion
07-Jan-2022 Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines Sanofi
07-Jan-2022 Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006 Neurimmune
07-Jan-2022 NICE recommends AbbVie’s RINVOQ® ▼ (upadacitinib) For Use in Adults with Active Psoriatic Arthritis AbbVie
07-Jan-2022 ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP PAION AG
07-Jan-2022 Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer Biotest AG
07-Jan-2022 SYNLAB acquires Sistemas Genómicos of the Ascires Group in Spain, further strengthening its European leadership in genetics SYNLAB AG
07-Jan-2022 MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance MorphoSys AG
07-Jan-2022 MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance MorphoSys AG
06-Jan-2022 Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform B3C newswire
06-Jan-2022 Oral decitabine and cedazuridine (ASTX727) granted Orphan Drug Designation (ODD) by the European Commission for the treatment of Acute Myeloid Leukaemia (AML) Otsuka Pharmaceutical Europe Ltd.
06-Jan-2022 Voluntis and AliveCor Partner to Advance Management of Atrial Fibrillation for Patients with Cancer Voluntis and AliveCor
06-Jan-2022 ONK Therapeutics Announces $21.5M Series A Financing to Advance Pipeline of Next-Generation Optimally Engineered Off-the-Shelf NK Cell Therapies ONK Therapeutics
06-Jan-2022 Future Fertility Raises Series A to Progress First-In-Class AI-Enabled Fertility Solutions to Improve IVF Outcomes Future Fertility,
06-Jan-2022 Valo Therapeutics Acquires University of Helsinki´s technology that capitalizes on pre-existing immunity acquired via childhood vaccination programs to potentiate the efficacy of cancer treatment Valo Therapeutics
06-Jan-2022 Median Technologies announces outstanding lung nodule detection (CADe[1]) performance for iBiopsy® Lung Cancer Screening Median Technologies
06-Jan-2022 French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance ARPEGE
06-Jan-2022 F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration F-star Therapeutics
06-Jan-2022 PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone PureTech Health plc
06-Jan-2022 Cannovum AG now offers Next Day Delivery for med. cannabis Cannovum AG